234 results on '"Herman, Robert"'
Search Results
2. Association of Mild-to-Moderate Aortic Regurgitation With Outcomes in Heart Failure With Preserved Ejection Fraction
- Author
-
De Colle, Cristina, Paolisso, Pasquale, Gallinoro, Emanuele, Bertolone, Dario Tino, Mileva, Niya, Fabbricatore, Davide, Valeriano, Chiara, Herman, Robert, Beles, Monika, De Oliveira, Elayne Kelen, Mancusi, Costantino, Heggermont, Ward, Collet, Carlos, Vanderheyden, Marc, De Luca, Nicola, Van Camp, Guy, Barbato, Emanuele, Bartunek, Jozef, and Penicka, Martin
- Abstract
To assess aortic regurgitation (AR) prevalence, its hemodynamic effect, and long-term prognostic implications in patients admitted with de novo or worsened heart failure with preserved ejection fraction (HFpEF).
- Published
- 2023
- Full Text
- View/download PDF
3. Sequential measurement of the neurosensory retina in hypertensive disorders of pregnancy: a model of microvascular injury in hypertensive emergency
- Author
-
Herman, Robert J., Ambasta, Anshula, Williams, R. Geoff, Zarnke, Kelly B., Costello, Fiona E., Peng, Mingkai, and Hawkins, T. Lee-Ann
- Abstract
Optical coherence tomography of the eye suggests the retina thins in normal pregnancy. Our objectives were to confirm and extend these observations to women with hypertensive disorders of pregnancy (HDP). Maternal demographics, clinical/laboratory findings and measurements of macular thickness were repeatedly collected at gestational ages <20 weeks, 20-weeks to delivery, at delivery and postpartum. The primary outcome was the change in macular thickness from non-pregnant dimensions in women with incident HDP compared to non-hypertensive pregnant controls. Secondary outcomes were the relationship(s) between mean arterial pressure (MAP) and macular response. Data show macular thicknesses diminished at <20 weeks gestation in each of 27 pregnancies ending in HDP (mean 3.94 µm; 95% CI 4.66, 3.21) and 11 controls (mean 3.92 µm; 5.05, 2.79; P< 0.001 versus non-pregnant dimensions in both; P= 0.983 HDP versus controls). This thinning response continued to delivery in all controls and in 7 women with HDP superimposed on chronic hypertension. Macular thinning was lost after 20 weeks gestation in the other 20 women with HDP. MAP at loss of macular thinning in women without prior hypertension (n= 12) was identical to MAP at enrollment. However, mean MAP subsequently rose 19 mmHg (15, 22) leading to de novo HDP in all 12 women. Loss of thinning leading to a rise in MAP was also observed in 8 of 15 women with HDP superimposed on chronic hypertension. We conclude the macula thins in most women in early pregnancy. Those who lose this early macular thinning response often develop blood pressure elevations leading to HDP.
- Published
- 2023
- Full Text
- View/download PDF
4. What's the difference? The task is daunting, and the challenges are complex. Has the Americans with Disabilities Act allowed greater participation in society?
- Author
-
Herman, Robert
- Subjects
Disabled persons -- Social aspects ,Disabled persons -- Surveys ,Disability -- Care and treatment ,Disability rights ,Americans with Disabilities Act of 1990 - Abstract
July 26, 2004, marked the 14th anniversary of the signing of the Americans with Disabilities Act (ADA). On July 26, 1990, as President George H. W. Bush signed the legislation [...]
- Published
- 2004
5. Readers' perceptions of philanthropy and nonprofit management journals.
- Author
-
Brudney, Jeffrey L. and Herman, Robert D.
- Subjects
Readers (People) -- Beliefs, opinions and attitudes ,Nonprofit organizations -- Public opinion ,Political/non-profit organization software - Published
- 2004
6. It's not a perfect world: (Part 1)
- Author
-
McCloskey, Maureen and Herman, Robert
- Subjects
Government regulation ,United States. Department of Transportation -- Laws, regulations and rules ,United States. Department of Veterans Affairs -- Standards ,Parking lots -- Laws, regulations and rules ,Parking enforcement agents ,Americans with Disabilities Act of 1990 - Abstract
AAAAARRGH! PARKING!!! How many times have you pulled into a lot only to find no accessible-parking spots available? (Try a sporting event or holiday shopping.) Or someone parked there without [...]
- Published
- 2004
7. Board practices of especially effective and less effective local nonprofit organizations.
- Author
-
Herman, Robert D. and Renz, David O.
- Subjects
Nonprofit organizations -- Management ,Corporate directors -- Management - Published
- 2000
8. Effects of early defibrillation by ambulance personnel on short- and long-term outcome of cardiac arrest survival: the Munich experiment
- Author
-
Ladwig, Karl-Heinz, Schoefinius, Andreas, Danner, Reinhold, Gurtler, Rolf, Herman, Robert, Koeppel, Andreas, and Hauber, Peter
- Subjects
Heart attack -- Prognosis ,Electric countershock -- Evaluation ,Emergency medical services -- Evaluation ,Health ,Evaluation ,Prognosis - Abstract
Objectives: This study evaluates the feasibility of implementing early defibrillation of out-of-hospital cardiac arrest patients for basic life-support Providers (EMT-D) in a two-tier emergency system in the city of Munich, [...]
- Published
- 1997
9. High glucose attenuates peptide agonist-evoked increases in cytosolic free ^Ca2+! in rat aortic smooth muscle cells
- Author
-
Sandirasegarane, Lakshman, Herman, Robert J., and Gopalakrishnan, Venkat
- Subjects
Diabetic angiopathies -- Risk factors ,Glucose metabolism -- Physiological aspects -- Health aspects ,Hyperglycemia -- Health aspects -- Risk factors ,Health ,Physiological aspects ,Risk factors ,Health aspects - Abstract
Incubation of cultured rat aortic smooth muscle cells (ASMCs) in a medium containing high glucose concentrations (25 mM) did not affect the basal cytosolic free calcium ([[[Ca.sup.2+]].sub.i]) but led to [...]
- Published
- 1994
10. Technology, human interaction, and complexity: reflections on vehicular traffic science
- Author
-
Herman, Robert
- Subjects
Traffic engineering -- Research ,Traffic flow -- Research ,Business ,Mathematics - Abstract
An overview of key developments in the field of vehicular traffic science over a 30-year period is presented. The overview highlights the key issues of interest in research areas such as car-following theory, urban traffic patterns, traffic system dynamics, and fuel consumption studies. The overview stresses the importance of collective and complexity effects in these research areas and yields the conclusion that vehicular traffic science must be viewed within the context of both the infrastructure that determines it and the technological environment that makes it a necessary field of study.
- Published
- 1992
11. Managing Voluntary and Non-Profit Organizations
- Author
-
Herman, Robert D.
- Subjects
Managing Voluntary and Non-Profit Organizations (Book) ,Books -- Book reviews ,Government ,Law - Abstract
Managing Voluntary and Non-profit Organizations. By Richard J. Butler and David C. Wilson. New York: Routledge, Chapman & Hall, 1990. Hardcover, $55.00. Pp. 190. Written by two well-known British management [...]
- Published
- 1991
12. An investigation of leadership skill differences in chief executives of nonprofit organizations
- Author
-
Herman, Robert D. and Heimovics, Richard D.
- Subjects
Chief executive officers -- Evaluation ,Leadership -- Evaluation ,Organizational behavior -- Research ,Nonprofit organizations -- Officials and employees ,Government ,Law - Abstract
An Investigation of Leadership Skill Differences in Chief Executives of Nonprofit Organizations Abstract: The increasing recognition of the public nature of nonprofit organizations and the changing relationships between governments and [...]
- Published
- 1990
13. It's not a perfect world: (Part 2)
- Author
-
McCloskey, Maureen and Herman, Robert
- Subjects
Company legal issue ,Government regulation ,Washington. Utilities and Transportation Commission -- Cases ,Paralyzed Veterans of America -- Cases ,Paralyzed Veterans of America -- Services ,Access for the disabled -- Cases ,Americans with Disabilities Act of 1990 - Abstract
In 1998, Arlington County, Va., joined the growing number of jurisdictions that have implemented ordinances eliminating free parking at meters for vehicles displaying valid handicap license plates and placards. The [...]
- Published
- 2004
14. Toward comprehensive uncertainty predictions for remote imaging spectroscopy
- Author
-
Ientilucci, Emmett J., Mouroulis, Pantazis, Thompson, David R., Brodrick, Philip G., Bohn, Niklas, Braverman, Amy, Carmon, Nimrod, Connelly, David, Fahlen, Jay, Green, Robert O., Herman, Robert L., Hobbs, Jonathan, Johnson, Margaret, Mahowald, Natalie, Okin, Gregory S., Poulter, Benjamin, Serbin, Shawn, Shiklomonov, Alexey N., Susiluoto, Jouni, and Turmon, Michael
- Published
- 2020
- Full Text
- View/download PDF
15. Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
- Author
-
Rabi, Doreen M., McBrien, Kerry A., Sapir-Pichhadze, Ruth, Nakhla, Meranda, Ahmed, Sofia B., Dumanski, Sandra M., Butalia, Sonia, Leung, Alexander A., Harris, Kevin C., Cloutier, Lyne, Zarnke, Kelly B., Ruzicka, Marcel, Hiremath, Swapnil, Feldman, Ross D., Tobe, Sheldon W., Campbell, Tavis S., Bacon, Simon L., Nerenberg, Kara A., Dresser, George K., Fournier, Anne, Burgess, Ellen, Lindsay, Patrice, Rabkin, Simon W., Prebtani, Ally P.H., Grover, Steven, Honos, George, Alfonsi, Jeffrey E., Arcand, JoAnne, Audibert, François, Benoit, Geneviève, Bittman, Jesse, Bolli, Peter, Côté, Anne-Marie, Dionne, Janis, Don-Wauchope, Andrew, Edwards, Cedric, Firoz, Tabassum, Gabor, Jonathan Y., Gilbert, Richard E., Grégoire, Jean C., Gryn, Steven E., Gupta, Milan, Hannah-Shmouni, Fady, Hegele, Robert A., Herman, Robert J., Hill, Michael D., Howlett, Jonathan G., Hundemer, Gregory L., Jones, Charlotte, Kaczorowski, Janusz, Khan, Nadia A., Kuyper, Laura M., Lamarre-Cliche, Maxime, Lavoie, Kim L., Leiter, Lawrence A., Lewanczuk, Richard, Logan, Alexander G., Magee, Laura A., Mangat, Birinder K., McFarlane, Philip A., McLean, Donna, Michaud, Andre, Milot, Alain, Moe, Gordon W., Penner, S. Brian, Pipe, Andrew, Poppe, Alexandre Y., Rey, Evelyne, Roerecke, Michael, Schiffrin, Ernesto L., Selby, Peter, Sharma, Mike, Shoamanesh, Ashkan, Sivapalan, Praveena, Townsend, Raymond R., Tran, Karen, Trudeau, Luc, Tsuyuki, Ross T., Vallée, Michel, Woo, Vincent, Bell, Alan D., and Daskalopoulou, Stella S.
- Abstract
Hypertension Canada’s 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Canada develops the guidelines using rigourous methodology, carefully mitigating the risk of bias in our process. All draft recommendations undergo critical review by expert methodologists without conflict to ensure quality. Our guideline panel is diverse, including multiple health professional groups (nurses, pharmacy, academics, and physicians), and worked in concert with experts in primary care and implementation to ensure optimal usability. The 2020 guidelines include new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.
- Published
- 2020
- Full Text
- View/download PDF
16. LETTERS.
- Author
-
HINDLE, LEON G., YATES, ROBERT, V. MCCARTHY, DANIEL, LEOPOLD, ROBERT, WEBB, HAN OR A., C. SUTTON, HENRY, GOEBEL, GEORGE H., LAMBERT, ELEANOR, HERMAN, ROBERT M., F. NEWTON, LEONARD, LEE, K. H., and ETZKORN, R. L.
- Subjects
VETO ,LOANS - Published
- 1947
17. Vehicular Traffic Flow.
- Author
-
Herman, Robert and Gardels, Keith
- Subjects
TRAFFIC flow ,TRAFFIC engineering ,AUTOMOTIVE transportation ,HIGHWAY engineering ,ROADS - Abstract
The article discusses theoretical approaches for improving traffic systems in the U.S. Previous attempts to improve the daily flow of vehicles between New Jersey and Manhattan, New York City were limited. Theoreticians then have created two conceptual approaches to traffic flow. The first approach features a macroscopic viewpoint. It views the vehicular stream as a compressible fluid. The second concept is focused on describing traffic flow based on the behavior of the individual driver.
- Published
- 1963
- Full Text
- View/download PDF
18. THE AMERICANS WITH DISABILITIES ACT: Ten Years Later
- Author
-
Herman, Robert N.
- Subjects
Disabled persons -- Laws, regulations and rules ,Americans with Disabilities Act of 1990 - Abstract
Are the "shameful walls of exclusion" really tumbline down. The disability community is busy planning activities to celebrate the tenth anniversary of the July 26, 1990, signing of the Americans [...]
- Published
- 2000
19. Wrangling over the Bang
- Author
-
Herman, Robert, Arp, Halton, Hartley, James, Mandel, Tom, and White, William E.
- Published
- 1991
20. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children
- Author
-
Nerenberg, Kara A., Zarnke, Kelly B., Leung, Alexander A., Dasgupta, Kaberi, Butalia, Sonia, McBrien, Kerry, Harris, Kevin C., Nakhla, Meranda, Cloutier, Lyne, Gelfer, Mark, Lamarre-Cliche, Maxime, Milot, Alain, Bolli, Peter, Tremblay, Guy, McLean, Donna, Padwal, Raj S., Tran, Karen C., Grover, Steven, Rabkin, Simon W., Moe, Gordon W., Howlett, Jonathan G., Lindsay, Patrice, Hill, Michael D., Sharma, Mike, Field, Thalia, Wein, Theodore H., Shoamanesh, Ashkan, Dresser, George K., Hamet, Pavel, Herman, Robert J., Burgess, Ellen, Gryn, Steven E., Grégoire, Jean C., Lewanczuk, Richard, Poirier, Luc, Campbell, Tavis S., Feldman, Ross D., Lavoie, Kim L., Tsuyuki, Ross T., Honos, George, Prebtani, Ally P.H., Kline, Gregory, Schiffrin, Ernesto L., Don-Wauchope, Andrew, Tobe, Sheldon W., Gilbert, Richard E., Leiter, Lawrence A., Jones, Charlotte, Woo, Vincent, Hegele, Robert A., Selby, Peter, Pipe, Andrew, McFarlane, Philip A., Oh, Paul, Gupta, Milan, Bacon, Simon L., Kaczorowski, Janusz, Trudeau, Luc, Campbell, Norman R.C., Hiremath, Swapnil, Roerecke, Michael, Arcand, Joanne, Ruzicka, Marcel, Prasad, G.V. Ramesh, Vallée, Michel, Edwards, Cedric, Sivapalan, Praveena, Penner, S. Brian, Fournier, Anne, Benoit, Geneviève, Feber, Janusz, Dionne, Janis, Magee, Laura A., Logan, Alexander G., Côté, Anne-Marie, Rey, Evelyne, Firoz, Tabassum, Kuyper, Laura M., Gabor, Jonathan Y., Townsend, Raymond R., Rabi, Doreen M., and Daskalopoulou, Stella S.
- Abstract
Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension in adults and children. This year, the adult and pediatric guidelines are combined in one document. The new 2018 pregnancy-specific hypertension guidelines are published separately. For 2018, 5 new guidelines are introduced, and 1 existing guideline on the blood pressure thresholds and targets in the setting of thrombolysis for acute ischemic stroke is revised. The use of validated wrist devices for the estimation of blood pressure in individuals with large arm circumference is now included. Guidance is provided for the follow-up measurements of blood pressure, with the use of standardized methods and electronic (oscillometric) upper arm devices in individuals with hypertension, and either ambulatory blood pressure monitoring or home blood pressure monitoring in individuals with white coat effect. We specify that all individuals with hypertension should have an assessment of global cardiovascular risk to promote health behaviours that lower blood pressure. Finally, an angiotensin receptor-neprilysin inhibitor combination should be used in place of either an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in individuals with heart failure (with ejection fraction < 40%) who are symptomatic despite appropriate doses of guideline-directed heart failure therapies. The specific evidence and rationale underlying each of these guidelines are discussed.
- Published
- 2018
- Full Text
- View/download PDF
21. Putting ACCOMPLISH into context: management of hypertension in 2010
- Author
-
McAlister, Finlay A., Herman, Robert J., Khan, Nadia A., Rabkin, Simon W., and Campbell, Norm
- Subjects
Hypertension -- Care and treatment -- Patient outcomes -- Control ,Health - Abstract
The much publicized Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH) trial (1) evaluated whether combination therapy with an angiotensinconverting enzyme (ACE) inhibitor (benazepril) and [...]
- Published
- 2010
- Full Text
- View/download PDF
22. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults
- Author
-
Leung, Alexander A., Daskalopoulou, Stella S., Dasgupta, Kaberi, McBrien, Kerry, Butalia, Sonia, Zarnke, Kelly B., Nerenberg, Kara, Harris, Kevin C., Nakhla, Meranda, Cloutier, Lyne, Gelfer, Mark, Lamarre-Cliche, Maxime, Milot, Alain, Bolli, Peter, Tremblay, Guy, McLean, Donna, Tobe, Sheldon W., Ruzicka, Marcel, Burns, Kevin D., Vallée, Michel, Prasad, G.V. Ramesh, Gryn, Steven E., Feldman, Ross D., Selby, Peter, Pipe, Andrew, Schiffrin, Ernesto L., McFarlane, Philip A., Oh, Paul, Hegele, Robert A., Khara, Milan, Wilson, Thomas W., Penner, S. Brian, Burgess, Ellen, Sivapalan, Praveena, Herman, Robert J., Bacon, Simon L., Rabkin, Simon W., Gilbert, Richard E., Campbell, Tavis S., Grover, Steven, Honos, George, Lindsay, Patrice, Hill, Michael D., Coutts, Shelagh B., Gubitz, Gord, Campbell, Norman R.C., Moe, Gordon W., Howlett, Jonathan G., Boulanger, Jean-Martin, Prebtani, Ally, Kline, Gregory, Leiter, Lawrence A., Jones, Charlotte, Côté, Anne-Marie, Woo, Vincent, Kaczorowski, Janusz, Trudeau, Luc, Tsuyuki, Ross T., Hiremath, Swapnil, Drouin, Denis, Lavoie, Kim L., Hamet, Pavel, Grégoire, Jean C., Lewanczuk, Richard, Dresser, George K., Sharma, Mukul, Reid, Debra, Lear, Scott A., Moullec, Gregory, Gupta, Milan, Magee, Laura A., Logan, Alexander G., Dionne, Janis, Fournier, Anne, Benoit, Geneviève, Feber, Janusz, Poirier, Luc, Padwal, Raj S., and Rabi, Doreen M.
- Abstract
Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis, assessment, prevention, and treatment of hypertension. This year, we introduce 10 new guidelines. Three previous guidelines have been revised and 5 have been removed. Previous age and frailty distinctions have been removed as considerations for when to initiate antihypertensive therapy. In the presence of macrovascular target organ damage, or in those with independent cardiovascular risk factors, antihypertensive therapy should be considered for all individuals with elevated average systolic nonautomated office blood pressure (non-AOBP) readings ≥ 140 mm Hg. For individuals with diastolic hypertension (with or without systolic hypertension), fixed-dose single-pill combinations are now recommended as an initial treatment option. Preference is given to pills containing an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in combination with either a calcium channel blocker or diuretic. Whenever a diuretic is selected as monotherapy, longer-acting agents are preferred. In patients with established ischemic heart disease, caution should be exercised in lowering diastolic non-AOBP to ≤ 60 mm Hg, especially in the presence of left ventricular hypertrophy. After a hemorrhagic stroke, in the first 24 hours, systolic non-AOBP lowering to < 140 mm Hg is not recommended. Finally, guidance is now provided for screening, initial diagnosis, assessment, and treatment of renovascular hypertension arising from fibromuscular dysplasia. The specific evidence and rationale underlying each of these guidelines are discussed.
- Published
- 2017
- Full Text
- View/download PDF
23. An in-depth evaluation and strategic guide to these all-new provisions.
- Author
-
Herman, Robert M. and Short, Gary G.
- Subjects
Employee benefits -- Laws, regulations and rules ,Pension funds -- Laws, regulations and rules ,Tax Reform Act of 1986 - Published
- 1987
24. The new pension and employee benefit rules.
- Author
-
Herman, Robert H. and Short, Gary G.
- Subjects
Employee benefits -- Taxation ,Pensions -- Taxation ,Tax Reform Act of 1986 - Published
- 1987
25. The salient management skills: a conceptual framework for a curriculum for managers in nonprofit organizations
- Author
-
Heimovics, Richard D. and Herman, Robert D.
- Subjects
Public administration -- Curricula ,Management science -- Curricula ,Nonprofit organizations -- Management ,Government ,Law ,Company business management ,Management ,Curricula - Abstract
The Salient Management Skills: A Conceptual Framework for A Curriculum for Managers in Nonprofit Organizations Abstract: As the definition of public affairs and administration expands to encompass nonprofit organizations and [...]
- Published
- 1989
26. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
- Author
-
Leung, Alexander A., Nerenberg, Kara, Daskalopoulou, Stella S., McBrien, Kerry, Zarnke, Kelly B., Dasgupta, Kaberi, Cloutier, Lyne, Gelfer, Mark, Lamarre-Cliche, Maxime, Milot, Alain, Bolli, Peter, Tremblay, Guy, McLean, Donna, Tobe, Sheldon W., Ruzicka, Marcel, Burns, Kevin D., Vallée, Michel, Prasad, G.V. Ramesh, Lebel, Marcel, Feldman, Ross D., Selby, Peter, Pipe, Andrew, Schiffrin, Ernesto L., McFarlane, Philip A., Oh, Paul, Hegele, Robert A., Khara, Milan, Wilson, Thomas W., Penner, S. Brian, Burgess, Ellen, Herman, Robert J., Bacon, Simon L., Rabkin, Simon W., Gilbert, Richard E., Campbell, Tavis S., Grover, Steven, Honos, George, Lindsay, Patrice, Hill, Michael D., Coutts, Shelagh B., Gubitz, Gord, Campbell, Norman R.C., Moe, Gordon W., Howlett, Jonathan G., Boulanger, Jean-Martin, Prebtani, Ally, Larochelle, Pierre, Leiter, Lawrence A., Jones, Charlotte, Ogilvie, Richard I., Woo, Vincent, Kaczorowski, Janusz, Trudeau, Luc, Petrella, Robert J., Hiremath, Swapnil, Drouin, Denis, Lavoie, Kim L., Hamet, Pavel, Fodor, George, Grégoire, Jean C., Lewanczuk, Richard, Dresser, George K., Sharma, Mukul, Reid, Debra, Lear, Scott A., Moullec, Gregory, Gupta, Milan, Magee, Laura A., Logan, Alexander G., Harris, Kevin C., Dionne, Janis, Fournier, Anne, Benoit, Geneviève, Feber, Janusz, Poirier, Luc, Padwal, Raj S., and Rabi, Doreen M.
- Abstract
Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 new recommendations, as well as revisions to 2 previous recommendations. In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure. Also, although a serum lipid panel remains part of the routine laboratory testing for patients with hypertension, fasting and nonfasting collections are now considered acceptable. For individuals with secondary hypertension arising from primary hyperaldosteronism, adrenal vein sampling is recommended for those who are candidates for potential adrenalectomy. With respect to the treatment of hypertension, a new recommendation that has been added is for increasing dietary potassium to reduce blood pressure in those who are not at high risk for hyperkalemia. Furthermore, in selected high-risk patients, intensive blood pressure reduction to a target systolic blood pressure ≤ 120 mm Hg should be considered to decrease the risk of cardiovascular events. Finally, in hypertensive individuals with uncomplicated, stable angina pectoris, either a β-blocker or calcium channel blocker may be considered for initial therapy. The specific evidence and rationale underlying each of these recommendations are discussed. Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force will continue to provide annual updates.
- Published
- 2016
- Full Text
- View/download PDF
27. 5th AD at St. Vith: could the battle of the bulge have been prevented?
- Author
-
Herman, Robert W.
- Subjects
Military and naval science - Abstract
Dear ARMOR, I thoroughly enjoyed Captain Borows' article, 'Armor's Stand at St, Vith' in the March-April 2007 issue of ARMOR. My unit, Company C, 628 Tank Destroyer Battalion, probably owes [...]
- Published
- 2007
28. Hotel accessibility
- Author
-
Herman, Robert N.
- Subjects
Hotels and motels - Abstract
The following letter refers to "Hotel Change Needed," Readers Respond, April 2006: I can understand reader Gordon Di Paolo's frustration from personal experience. He's correct, though, that the Americans With [...]
- Published
- 2006
29. The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
- Author
-
Daskalopoulou, Stella S., Rabi, Doreen M., Zarnke, Kelly B., Dasgupta, Kaberi, Nerenberg, Kara, Cloutier, Lyne, Gelfer, Mark, Lamarre-Cliche, Maxime, Milot, Alain, Bolli, Peter, McKay, Donald W., Tremblay, Guy, McLean, Donna, Tobe, Sheldon W., Ruzicka, Marcel, Burns, Kevin D., Vallée, Michel, Ramesh Prasad, G.V., Lebel, Marcel, Feldman, Ross D., Selby, Peter, Pipe, Andrew, Schiffrin, Ernesto L., McFarlane, Philip A., Oh, Paul, Hegele, Robert A., Khara, Milan, Wilson, Thomas W., Brian Penner, S., Burgess, Ellen, Herman, Robert J., Bacon, Simon L., Rabkin, Simon W., Gilbert, Richard E., Campbell, Tavis S., Grover, Steven, Honos, George, Lindsay, Patrice, Hill, Michael D., Coutts, Shelagh B., Gubitz, Gord, Campbell, Norman R.C., Moe, Gordon W., Howlett, Jonathan G., Boulanger, Jean-Martin, Prebtani, Ally, Larochelle, Pierre, Leiter, Lawrence A., Jones, Charlotte, Ogilvie, Richard I., Woo, Vincent, Kaczorowski, Janusz, Trudeau, Luc, Petrella, Robert J., Hiremath, Swapnil, Stone, James A., Drouin, Denis, Lavoie, Kim L., Hamet, Pavel, Fodor, George, Grégoire, Jean C., Fournier, Anne, Lewanczuk, Richard, Dresser, George K., Sharma, Mukul, Reid, Debra, Benoit, Geneviève, Feber, Janusz, Harris, Kevin C., Poirier, Luc, and Padwal, Raj S.
- Abstract
The Canadian Hypertension Education Program reviews the hypertension literature annually and provides detailed recommendations regarding hypertension diagnosis, assessment, prevention, and treatment. This report provides the updated evidence-based recommendations for 2015. This year, 4 new recommendations were added and 2 existing recommendations were modified. A revised algorithm for the diagnosis of hypertension is presented. Two major changes are proposed: (1) measurement using validated electronic (oscillometric) upper arm devices is preferred over auscultation for accurate office blood pressure measurement; (2) if the visit 1 mean blood pressure is increased but < 180/110 mm Hg, out-of-office blood pressure measurements using ambulatory blood pressure monitoring (preferably) or home blood pressure monitoring should be performed before visit 2 to rule out white coat hypertension, for which pharmacologic treatment is not recommended. A standardized ambulatory blood pressure monitoring protocol and an update on automated office blood pressure are also presented. Several other recommendations on accurate measurement of blood pressure and criteria for diagnosis of hypertension have been reorganized. Two other new recommendations refer to smoking cessation: (1) tobacco use status should be updated regularly and advice to quit smoking should be provided; and (2) advice in combination with pharmacotherapy for smoking cessation should be offered to all smokers. The following recommendations were modified: (1) renal artery stenosis should be primarily managed medically; and (2) renal artery angioplasty and stenting could be considered for patients with renal artery stenosis and complicated, uncontrolled hypertension. The rationale for these recommendation changes is discussed.
- Published
- 2015
- Full Text
- View/download PDF
30. The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
- Author
-
Dasgupta, Kaberi, Quinn, Robert R., Zarnke, Kelly B., Rabi, Doreen M., Ravani, Pietro, Daskalopoulou, Stella S., Rabkin, Simon W., Trudeau, Luc, Feldman, Ross D., Cloutier, Lyne, Prebtani, Ally, Herman, Robert J., Bacon, Simon L., Gilbert, Richard E., Ruzicka, Marcel, McKay, Donald W., Campbell, Tavis S., Grover, Steven, Honos, George, Schiffrin, Ernesto L., Bolli, Peter, Wilson, Thomas W., Lindsay, Patrice, Hill, Michael D., Coutts, Shelagh B., Gubitz, Gord, Gelfer, Mark, Vallée, Michel, Prasad, G.V. Ramesh, Lebel, Marcel, McLean, Donna, Arnold, J. Malcolm O., Moe, Gordon W., Howlett, Jonathan G., Boulanger, Jean-Martin, Larochelle, Pierre, Leiter, Lawrence A., Jones, Charlotte, Ogilvie, Richard I., Woo, Vincent, Kaczorowski, Janusz, Burns, Kevin D., Petrella, Robert J., Hiremath, Swapnil, Milot, Alain, Stone, James A., Drouin, Denis, Lavoie, Kim L., Lamarre-Cliche, Maxime, Tremblay, Guy, Hamet, Pavel, Fodor, George, Carruthers, S. George, Pylypchuk, George B., Burgess, Ellen, Lewanczuk, Richard, Dresser, George K., Penner, S. Brian, Hegele, Robert A., McFarlane, Philip A., Khara, Milan, Pipe, Andrew, Oh, Paul, Selby, Peter, Sharma, Mukul, Reid, Debra J., Tobe, Sheldon W., Padwal, Raj S., and Poirier, Luc
- Abstract
Herein, updated evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in Canadian adults are detailed. For 2014, 3 existing recommendations were modified and 2 new recommendations were added. The following recommendations were modified: (1) the recommended sodium intake threshold was changed from ≤ 1500 mg (3.75 g of salt) to approximately 2000 mg (5 g of salt) per day; (2) a pharmacotherapy treatment initiation systolic blood pressure threshold of ≥ 160 mm Hg was added in very elderly (age ≥ 80 years) patients who do not have diabetes or target organ damage (systolic blood pressure target in this population remains at < 150 mm Hg); and (3) the target population recommended to receive low-dose acetylsalicylic acid therapy for primary prevention was narrowed from all patients with controlled hypertension to only those ≥ 50 years of age. The 2 new recommendations are: (1) advice to be cautious when lowering systolic blood pressure to target levels in patients with established coronary artery disease if diastolic blood pressure is ≤ 60 mm Hg because of concerns that myocardial ischemia might be exacerbated; and (2) the addition of glycated hemoglobin (A1c) in the diagnostic work-up of patients with newly diagnosed hypertension. The rationale for these recommendation changes is discussed. In addition, emerging data on blood pressure targets in stroke patients are discussed; these data did not lead to recommendation changes at this time. The Canadian Hypertension Education Program recommendations will continue to be updated annually.
- Published
- 2014
- Full Text
- View/download PDF
31. Renal Denervation Therapy for the Treatment of Resistant Hypertension: A Position Statement by the Canadian Hypertension Education Program
- Author
-
Khan, Nadia A., Herman, Robert J., Quinn, Robert R., Rabkin, Simon W., Ravani, Pietro, Tobe, Sheldon W., Feldman, Ross D., Wijeysundera, Harindra C., and Padwal, Raj S.
- Abstract
Renal denervation is a novel catheter-based, percutaneous procedure using radiofrequency energy to ablate nerves within the renal arteries. This procedure might help to significantly lower blood pressure (BP) in patients with resistant hypertension, defined as BP 140/90 mm Hg (130/80 mm Hg for those with diabetes) despite use of ≥ 3 optimally dosed antihypertensive agents, ideally including 1 diuretic agent. The Canadian Hypertension Education Program Recommendations Task Force reviewed the current evidence on safety and efficacy of this procedure. Eleven studies on renal denervation were examined and most of the evidence evaluating renal denervation was derived from the Symplicity studies. In patients with systolic BP ≥ 160 mm Hg (≥ 150 mm Hg for patients with type 2 diabetes) despite use of ≥ 3 antihypertensive agents, bilateral renal denervation was associated with significantly lower BP (−22/11 to −34/13 mm Hg) at 6 months with a low periprocedural complication rate. Few patients underwent 24-hour ambulatory BP monitoring and ambulatory BP monitoring showed more modest BP lowering (0 to −11/7 mm Hg). Although early results on short-term safety and blood pressure-lowering are encouraging, there are no long-term efficacy and safety data, or hard cardiovascular end point data. The discrepancy between office BP reductions and 24-hour ambulatory BP monitor reductions needs to be further investigated. Until more data are available, renal sympathetic denervation should be considered as a treatment option of last resort for patients with resistant hypertension who have exhausted all other available medical management options.
- Published
- 2014
- Full Text
- View/download PDF
32. The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
- Author
-
Hackam, Daniel G., Quinn, Robert R., Ravani, Pietro, Rabi, Doreen M., Dasgupta, Kaberi, Daskalopoulou, Stella S., Khan, Nadia A., Herman, Robert J., Bacon, Simon L., Cloutier, Lyne, Dawes, Martin, Rabkin, Simon W., Gilbert, Richard E., Ruzicka, Marcel, McKay, Donald W., Campbell, Tavis S., Grover, Steven, Honos, George, Schiffrin, Ernesto L., Bolli, Peter, Wilson, Thomas W., Feldman, Ross D., Lindsay, Patrice, Hill, Michael D., Gelfer, Mark, Burns, Kevin D., Vallée, Michel, Prasad, G.V. Ramesh, Lebel, Marcel, McLean, Donna, Arnold, J. Malcolm O., Moe, Gordon W., Howlett, Jonathan G., Boulanger, Jean-Martin, Larochelle, Pierre, Leiter, Lawrence A., Jones, Charlotte, Ogilvie, Richard I., Woo, Vincent, Kaczorowski, Janusz, Trudeau, Luc, Petrella, Robert J., Milot, Alain, Stone, James A., Drouin, Denis, Lavoie, Kim L., Lamarre-Cliche, Maxime, Godwin, Marshall, Tremblay, Guy, Hamet, Pavel, Fodor, George, Carruthers, S. George, Pylypchuk, George B., Burgess, Ellen, Lewanczuk, Richard, Dresser, George K., Penner, S. Brian, Hegele, Robert A., McFarlane, Philip A., Sharma, Mukul, Reid, Debra J., Tobe, Sheldon W., Poirier, Luc, and Padwal, Raj S.
- Abstract
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2013. This year's update includes 2 new recommendations. First, among nonhypertensive or stage 1 hypertensive individuals, the use of resistance or weight training exercise does not adversely influence blood pressure (BP) (Grade D). Thus, such patients need not avoid this type of exercise for fear of increasing BP. Second, and separately, for very elderly patients with isolated systolic hypertension (age 80 years or older), the target for systolic BP should be < 150 mm Hg (Grade C) rather than < 140 mm Hg as recommended for younger patients. We also discuss 2 additional topics at length (the pharmacological treatment of mild hypertension and the possibility of a diastolic J curve in hypertensive patients with coronary artery disease). In light of several methodological limitations, a recent systematic review of 4 trials in patients with stage 1 uncomplicated hypertension did not lead to changes in management recommendations. In addition, because of a lack of prospective randomized data assessing diastolic BP thresholds in patients with coronary artery disease and hypertension, no recommendation to set a selective diastolic cut point for such patients could be affirmed. However, both of these issues will be examined on an ongoing basis, in particular as new evidence emerges.
- Published
- 2013
- Full Text
- View/download PDF
33. Hedging with derivatives makes headway in Japan
- Author
-
Herman, Robert
- Subjects
Petroleum industry -- Finance ,Petroleum chemicals industry -- Finance ,Hedging (Finance) -- Usage ,Corporations, Japanese -- Finance ,Business ,Business, general - Abstract
Japanese oil companies have begun using the commodity traders tool of derivatives to protect their profits. The companies' interest rates are derived from their prices, so they pay less interest when oil prices are down. Japanese companies are using them with jet-fuel contracts, as airlines are demanding flexible pricing structures. Petrochemical firms have suffered recently from a reduced demand for plastics.
- Published
- 1993
34. The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy
- Author
-
Daskalopoulou, Stella S., Khan, Nadia A., Quinn, Robert R., Ruzicka, Marcel, McKay, Donald W., Hackam, Daniel G., Rabkin, Simon W., Rabi, Doreen M., Gilbert, Richard E., Padwal, Raj S., Dawes, Martin, Touyz, Rhian M., Campbell, Tavis S., Cloutier, Lyne, Grover, Steven, Honos, George, Herman, Robert J., Schiffrin, Ernesto L., Bolli, Peter, Wilson, Thomas, Feldman, Ross D., Lindsay, M. Patrice, Hemmelgarn, Brenda R., Hill, Michael D., Gelfer, Mark, Burns, Kevin D., Vallée, Michel, Prasad, G.V. Ramesh, Lebel, Marcel, McLean, Donna, Arnold, J. Malcolm O., Moe, Gordon W., Howlett, Jonathan G., Boulanger, Jean-Martin, Larochelle, Pierre, Leiter, Lawrence A., Jones, Charlotte, Ogilvie, Richard I., Woo, Vincent, Kaczorowski, Janusz, Trudeau, Luc, Bacon, Simon L., Petrella, Robert J., Milot, Alain, Stone, James A., Drouin, Denis, Lamarre-Cliché, Maxime, Godwin, Marshall, Tremblay, Guy, Hamet, Pavel, Fodor, George, Carruthers, S. George, Pylypchuk, George, Burgess, Ellen, Lewanczuk, Richard, Dresser, George K., Penner, Brian, Hegele, Robert A., McFarlane, Philip A., Sharma, Mukul, Campbell, Norman R.C., Reid, Debra, Poirier, Luc, and Tobe, Sheldon W.
- Abstract
We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2012. The new recommendations are: (1) use of home blood pressure monitoring to confirm a diagnosis of white coat syndrome; (2) mineralocorticoid receptor antagonists may be used in selected patients with hypertension and systolic heart failure; (3) a history of atrial fibrillation in patients with hypertension should not be a factor in deciding to prescribe an angiotensin-receptor blocker for the treatment of hypertension; and (4) the blood pressure target for patients with nondiabetic chronic kidney disease has now been changed to < 140/90 mm Hg from < 130/80 mm Hg. We also reviewed the recent evidence on blood pressure targets for patients with hypertension and diabetes and continue to recommend a blood pressure target of less than 130/80 mm Hg.
- Published
- 2012
- Full Text
- View/download PDF
35. Cardiovascular risk profiles and outcomes of Chinese living inside and outside China
- Author
-
Chiu, John F., Bell, Alan D., Herman, Robert J., Hill, Michael D., Stewart, John A., Cohen, Eric A., Liau, Chiau-Suong, Steg, P. Gabriel, and Bhatt, Deepak L.
- Abstract
Aim To assess whether cardiovascular risk differs among the Chinese living inside and outside mainland China.Methods and results Three thousand, four hundred and eighty-two East Asians were enrolled in the REduction of Atherothrombosis for Continued Health Registry in mainland China, Hong Kong/Singapore/Taiwan, Western Europe, and North America. Baseline demographics, medication use, risk factor control, and 30-month cardiovascular outcomes of the 2938 patients with atherothrombotic disease were compared. Rates of hypertension, hypercholesterolemia, diabetes, abdominal obesity, and body mass index ≥ 25 kg/m2were lowest in mainland China, were increased in Hong Kong/Singapore/Taiwan, and were highest in Western Europe and North America. Diabetes prevalence was 23% in mainland China, approximately two-fold lower than the other regions. Antihypertensive, antidiabetic, and antiplatelet agent use was similar in all regions. Risk factor control was significantly poorer in Western Europe and, except for glucose control, significantly better in North America. Thirty-month nonfatal stroke rates were highest in mainland China and fell in a stepwise manner in more westernized societies. Conversely, nonfatal myocardial infarction rates increased in more westernized societies.Conclusion Obesity and other risk factors progressively worsen as patients move from mainland China to Hong Kong/ Singapore/Taiwan and overseas. Despite similar medication use, risk factor control and cardiovascular outcomes were significantly different. The magnitude of these changes is larger than formerly estimated, suggesting population differences in cardiovascular risk and disease prevalence, likely to be more closely associated with lifestyle and cultural habits than genetic differences.
- Published
- 2010
- Full Text
- View/download PDF
36. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy
- Author
-
Hackam, Daniel G., Khan, Nadia A., Hemmelgarn, Brenda R., Rabkin, Simon W., Touyz, Rhian M., Campbell, Norman R.C., Padwal, Raj, Campbell, Tavis S., Patrice Lindsay, M., Hill, Michael D., Quinn, Robert R., Mahon, Jeff L., Herman, Robert J., Schiffrin, Ernesto L., Ruzicka, Marcel, Larochelle, Pierre, Feldman, Ross D., Lebel, Marcel, Poirier, Luc, Arnold, J. Malcolm O., Moe, Gordon W., Howlett, Jonathan G., Trudeau, Luc, Bacon, Simon L., Petrella, Robert J., Milot, Alain, Stone, James A., Drouin, Denis, Boulanger, Jean-Martin, Sharma, Mukul, Hamet, Pavel, Fodor, George, Dresser, George K., George Carruthers, S., Pylypchuk, George, Burgess, Ellen D., Burns, Kevin D., Vallée, Michel, Ramesh Prasad, G.V., Gilbert, Richard E., Leiter, Lawrence A., Jones, Charlotte, Ogilvie, Richard I., Woo, Vincent, McFarlane, Philip A., Hegele, Robert A., and Tobe, Sheldon W.
- Abstract
To update the evidence-based recommendations for the prevention and treatment of hypertension in adults for 2010.
- Published
- 2010
- Full Text
- View/download PDF
37. Management of atherothrombotic risk factors in high-risk Canadian outpatients
- Author
-
Bell, Alan, Hill, Michael D., Herman, Robert J., Girard, Manon, and Cohen, Eric
- Abstract
The REduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective cohort of 68,236 patients with established coronary artery, cerebrovascular or peripheral arterial disease, or three or more atherothrombotic risk factors. Baseline data from the 1976 Canadian patients in the REACH Registry provide opportunities to assess atherothrombotic risk and treatment in a real-world Canadian setting.
- Published
- 2009
- Full Text
- View/download PDF
38. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy
- Author
-
Khan, Nadia A., Hemmelgarn, Brenda, Herman, Robert J., Bell, Chaim M., Mahon, Jeff L., Leiter, Lawrence A., Rabkin, Simon W., Hill, Michael D., Padwal, Raj, Touyz, Rhian M., Larochelle, Pierre, Feldman, Ross D., Schiffrin, Ernesto L., Campbell, Norman R.C., Moe, Gordon, Prasad, Ramesh, Arnold, Malcolm O., Campbell, Tavis S., Milot, Alain, Stone, James A., Jones, Charlotte, Ogilvie, Richard I., Hamet, Pavel, Fodor, George, Carruthers, George, Burns, Kevin D., Ruzicka, Marcel, deChamplain, Jacques, Pylypchuk, George, Petrella, Robert, Boulanger, Jean-Martin, Trudeau, Luc, Hegele, Robert A., Woo, Vincent, McFarlane, Phil, Vallée, Michel, Howlett, Jonathan, Bacon, Simon L., Lindsay, Patrice, Gilbert, Richard E., Lewanczuk, Richard Z., and Tobe, Sheldon
- Abstract
To update the evidence-based recommendations for the prevention and management of hypertension in adults for 2009.
- Published
- 2009
- Full Text
- View/download PDF
39. Abstract 13836: Unbiased Deep Learning Approach Utilizing Longitudinal Data in Assessing All-Cause Mortality in Patients With a De Novoor Worsened Heart Failure
- Author
-
Herman, Robert, Vanderheyden, Marc, Vavrik, Boris, Beles, Monika, Palus, Timotej, Kepesiova, Zuzana, Goethals, Marc, Verstreken, Sofie, Dierckx, Riet, Heggermont, Ward, and Bartunek, Jozef
- Abstract
Introduction:Heart failure (HF) is a heterogenous syndrome with complex pathophysiology. Biomarkers and clinical risk scores often fail to capture modifications in the treatment continuity and provide suboptimal patient-level precision in the prognostic stratification. Electronic patient records provide necessary granularity yielding opportunities to develop new artificial intelligence (AI) based strategies for comprehensive prognostic re-stratification.Hypothesis:We assessed the hypothesis that, utilizing longitudinal patient data in an AI approach, yields superior performance predicting all-cause mortality in a cohort of patients hospitalized with a de novoor worsened HF, compared to single observational time point predictions.Methods:In a cohort of 2449 HF patients hospitalized between 2011-2017, we utilized 151 451 patient exams from 422 parameters. Features included clinical phenotyping, medication, ECG, laboratory, echocardiography, catheterization data or percutaneous and surgical interventions gathered on a routine clinical basis reflecting standard of care as captured in individual electronic records. AI models were developed, and their performance on the validation set was compared to industry standard clinical scores.Results:AI models yielded performance ranging from 0.83 to 0.89 AUC on the outcome-balanced validation set in predicting all-cause mortality at 30-, 90-, 180-, 360- and 720-day time-limits. The primary endpoint, 1-year mortality prediction model, recorded 0.85 AUC on the validation set compared to 0.7 AUC (Seattle HF model) and 0.73 AUC (MAGGIC HF Score) respectively.Conclusions:Our findings present a novel, patient-level, AI-based risk prediction approach of all-cause mortality in heart failure utilizing all historical data available in electronic health records. This suggests the potential of AI based predictive models in a point-of-care approach to guide clinical risk stratification.
- Published
- 2021
- Full Text
- View/download PDF
40. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy
- Author
-
Khan, Nadia A., Hemmelgarn, Brenda, Herman, Robert J., Rabkin, Simon W., McAlister, Finlay A., Bell, Chaim M., Touyz, Rhian M., Padwal, Raj, Leiter, Lawrence A., Mahon, Jeff L., Hill, Michael D., Larochelle, Pierre, Feldman, Ross D., Schiffrin, Ernesto L., Campbell, Norman R.C., Arnold, Malcolm O., Moe, Gordon, Campbell, Tavis S., Milot, Alain, Stone, James A., Jones, Charlotte, Ogilvie, Richard I., Hamet, Pavel, Fodor, George, Carruthers, George, Burns, Kevin D., Ruzicka, Marcel, deChamplain, Jacques, Pylypchuk, George, Petrella, Robert, Boulanger, Jean-Martin, Trudeau, Luc, Hegele, Robert A., Woo, Vincent, McFarlane, Phil, Vallée, Michel, Howlett, Jonathan, Katzmarzyk, Peter, Tobe, Sheldon, and Lewanczuk, Richard Z.
- Abstract
To update the evidence-based recommendations for the prevention and management of hypertension in adults.
- Published
- 2008
- Full Text
- View/download PDF
41. Japan oil product pricing hinders growth of commodity derivatives
- Author
-
Twaronite, Lisa and Herman, Robert
- Subjects
Japan. Ministry of International Trade and Industry -- Laws, regulations and rules ,Japan -- Economic policy ,Petroleum industry -- Economic aspects ,Hedging (Finance) -- Japan ,Petroleum -- Futures ,Business ,Business, general - Abstract
An identified Japanese oil company was reported to be using commodity derivatives to hedge its overseas refinery margins in Singapore. However, the Ministry of International Trade and Industry is expected to prevent the development of a domestic market for similar derivatives. Japanese oil prices are higher in Japan compared to international prices but state control of adverse price movements does not require the use of derivatives.
- Published
- 1992
42. Rising crude imports may spur Japanese use of swaps for hedging
- Author
-
Twaronite, Lisa, Herman, Robert, and Mongeon, Luc
- Subjects
Japan -- International trade ,Petroleum industry -- International trade ,Commodity swaps -- Analysis ,Business ,Business, general - Abstract
More Japanese trading houses and refineries may use oil-linked financial swaps for hedging due to the rising Japanese crude oil imports as compared to declining oil product imports. Japan imports oil mostly from Persian Gulf suppliers but lacks a body equivalent to the New York Mercantile Exchange or London's International Petroleum Exchange on which to counterbalance increase market price in crude oil imports.
- Published
- 1992
43. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy
- Author
-
Khan, Nadia A., Hemmelgarn, Brenda, Padwal, Raj, Larochelle, Pierre, Mahon, Jeff L., Lewanczuk, Richard Z., McAlister, Finlay A., Rabkin, Simon W., Hill, Michael D, Feldman, Ross D., Schiffrin, Ernesto L., Campbell, Norman R.C., Logan, Alexander G., Arnold, Malcolm, Moe, Gordon, Campbell, Tavis S., Milot, Alain, Stone, James A., Jones, Charlotte, Leiter, Lawrence A., Ogilvie, Richard I., Herman, Robert J., Hamet, Pavel, Fodor, George, Carruthers, George, Culleton, Bruce, Burns, Kevin D., Ruzicka, Marcel, deChamplain, Jacques, Pylypchuk, George, Gledhill, Norm, Petrella, Robert, Boulanger, Jean-Martin, Trudeau, Luc, Hegele, Robert A., Woo, Vincent, McFarlane, Phil, Touyz, Rhian M., and Tobe, Sheldon W.
- Abstract
To provide updated, evidence-based recommendations for the prevention and management of hypertension in adults.
- Published
- 2007
- Full Text
- View/download PDF
44. The Legacy of Ernst Pagels, Horticulture Icon, Lives in Gardens and Gardeners Around the World.
- Author
-
Herman, Robert
- Abstract
The article presents an obituary for perennial plant enthusiast, Ernst Pagels.
- Published
- 2007
45. Carbamazepine Toxicity Induced by Lopinavir/Ritonavir and Nelfinavir
- Author
-
Bates, Duane E and Herman, Robert J
- Abstract
Objective: To present a case of carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.Case Summary: A 50-year-old HIV-positive male developed excessive drowsiness secondary to carbamazepine when an antiretroviral regimen containing lopinavir/ritonavir was introduced. The carbamazepine serum concentration increased 46%. Subsequently, the patient developed a possible adverse skin reaction to his antiretrovirals and was hospitalized. The protease inhibitor was changed to nelfinavir. Within 3 days, the patient again developed excessive drowsiness and became unsteady on his feet. This time, the carbamazepine serum concentration had increased by 53%. In both instances, the carbamazepine dosage was decreased by 33%, which resulted in resolution of symptoms.Discussion: Carbamazepine undergoes extensive hepatic metabolism. The major metabolic pathway involves oxidation of carbamazepine via CYP3A4 to an active metabolite, carbamazepine-10,11-epoxide. Protease inhibitors are well-known CYP3A4 inhibitors. Other cases of carbamazepine toxicity secondary to protease inhibitors are reviewed. A MEDLINE search (1966–May 2006) revealed 4 cases of carbamazepine toxicity secondary to antiretrovirals. Carbamazepine serum concentrations increased two- to threefold from baseline. Vertigo, drowsiness, disorientation, ataxia, and vomiting occurred within 12 hours to 2 months, which resolved with reduction of the carbamazepine dosage.Conclusions: An objective causality assessment suggests that our patient became drowsy and unsteady on his feet secondary to a carbamazepine–protease inhibitor interaction. Lopinavir/ritonavir and nelfinavir may decrease carbamazepine metabolism, causing an elevation in carbamazepine serum concentrations. Carbamazepine toxicity may be prevented by reducing the carbamazepine dosage by 25–50% when protease inhibitors are introduced. A carbamazepine serum concentration should be repeated 3–5 days after the protease inhibitors are started.
- Published
- 2006
- Full Text
- View/download PDF
46. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy
- Author
-
Khan, Nadia A., McAlister, Finlay A., Rabkin, Simon W., Padwal, Raj, Feldman, Ross D., Campbell, Norman R.C., Leiter, Lawrence A., Lewanczuk, Richard Z., Schiffrin, Ernesto L., Hill, Michael D., Arnold, Malcolm, Moe, Gordon, Campbell, Tavis S., Herbert, Carol, Milot, Alain, Stone, James A., Burgess, Ellen, Hemmelgarn, B., Jones, Charlotte, Larochelle, Pierre, Ogilvie, Richard I., Houlden, Robyn, Herman, Robert J., Hamet, Pavel, Fodor, George, Carruthers, George, Culleton, Bruce, deChamplain, Jacques, Pylypchuk, George, Logan, Alexander G., Gledhill, Norm, Petrella, Robert, Tobe, Sheldon, and Touyz, Rhian M.
- Abstract
To provide updated, evidence-based recommendations for the management of hypertension in adults.
- Published
- 2006
- Full Text
- View/download PDF
47. Isopentenyl-diphosphate isomerase is essential for viability of Caenorhabditis elegans
- Author
-
Yochem, John, Hall, David H., Bell, Leslie R., Hedgecock, Edward M., and Herman, Robert K.
- Abstract
Abstract Homozygosity for a mutation in the idi-1 gene of Caenorhabditis elegans results in paralysis during the first larval stage, followed by an arrest of growth and development late in the first larval stage. Apoptotic corpses, which are apparently the result of normal programmed cell death, persist in the arrested larvae. In genetic mosaics, an additional defect becomes evident upon examination with Nomarski optics: cells that are genotypically mutant enlarge, and their cytoplasm becomes dimpled. Electron microscopy indicates that the dimpling reflects an accumulation of many enlarged lysosomes and autophagosomes. The mosaics demonstrate that the lethal mutation acts cell autonomously with respect to this vesicular abnormality and that there is a maternal effect with respect to the time of developmental arrest of mutant progeny. Cloning of the gene reveals that it is the only gene in C. elegans for isopentenyl-diphosphate isomerase, an enzyme that is important for the synthesis of lipophilic molecules, including farnesyl and geranyl diphosphates.
- Published
- 2005
- Full Text
- View/download PDF
48. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program
- Author
-
Campbell, Norman RC, McAlister, Finlay A, Brant, Rollin, Levine, Mitch, Drouin, Denis, Feldman, Ross, Herman, Robert, and Zarnke, Kelly
- Abstract
Poor control of hypertension is a world-wide health issue. In 1999, the Canadian Hypertension Education Program (CHEP) was launched to annually develop and implement evidence-based hypertension guidelines in an effort to improve hypertension control rates. This study was designed to examine temporal trends in antihypertensive drug prescribing and to explore whether drug prescriptions changed after initiation of the new CHEP guideline process.
- Published
- 2003
49. MEC-8 regulates alternative splicing of unc-52 transcripts inC. elegans hypodermal cells
- Author
-
Spike, Caroline A., Davies, Andrew G., Shaw, Jocelyn E., and Herman, Robert K.
- Abstract
Previous work has shown that C. elegans MEC-8 is a putative RNA-binding protein that promotes specific alternative splices ofunc-52 transcripts. unc-52 encodes homologs of mammalian perlecan that are located extracellularly between muscle and hypodermis and are essential for muscle development in both embryos and larvae. We show that MEC-8 is a nuclear protein found in hypodermis at most stages of development and not in most late embryonic or larval body-wall muscle. We have also found that overexpression of MEC-8 in hypodermis but not muscle can suppress certainunc-52 mutant phenotypes. These are unexpected results because it has been proposed that UNC-52 is produced exclusively by muscle. We have constructed various tissue-specific unc-52 minigenes fused to a gene for green fluorescent protein that have allowed us to monitor tissue-specificmec-8-dependent alternative splicing; we show that mec-8must be expressed in the same cell type as the unc-52 minigene in order to regulate its expression, supporting the view that MEC-8 acts directly on unc-52 transcripts and that UNC-52 must be synthesized primarily by the hypodermis. Indeed, our analysis of unc-52 genetic mosaics has shown that the focus of unc-52 action is not in body-wall muscle but most likely is in hypodermis.
- Published
- 2002
- Full Text
- View/download PDF
50. MEC-8 regulates alternative splicing of unc-52 transcripts in C. elegans hypodermal cells.
- Author
-
A, Spike Caroline, G, Davies Andrew, E, Shaw Jocelyn, and K, Herman Robert
- Abstract
Previous work has shown that C. elegans MEC-8 is a putative RNA-binding protein that promotes specific alternative splices of unc-52 transcripts. unc-52 encodes homologs of mammalian perlecan that are located extracellularly between muscle and hypodermis and are essential for muscle development in both embryos and larvae. We show that MEC-8 is a nuclear protein found in hypodermis at most stages of development and not in most late embryonic or larval body-wall muscle. We have also found that overexpression of MEC-8 in hypodermis but not muscle can suppress certain unc-52 mutant phenotypes. These are unexpected results because it has been proposed that UNC-52 is produced exclusively by muscle. We have constructed various tissue-specific unc-52 minigenes fused to a gene for green fluorescent protein that have allowed us to monitor tissue-specific mec-8-dependent alternative splicing; we show that mec-8 must be expressed in the same cell type as the unc-52 minigene in order to regulate its expression, supporting the view that MEC-8 acts directly on unc-52 transcripts and that UNC-52 must be synthesized primarily by the hypodermis. Indeed, our analysis of unc-52 genetic mosaics has shown that the focus of unc-52 action is not in body-wall muscle but most likely is in hypodermis.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.